180 related articles for article (PubMed ID: 32787515)
1. Treatment of Renin-Angiotensin-Aldosterone System Dysfunction With Angiotensin II in High-Renin Septic Shock.
Chow JH; Wallis M; Lankford AS; Chancer Z; Barth RN; Scalea JR; LaMattina JC; Mazzeffi MA; McCurdy MT
Semin Cardiothorac Vasc Anesth; 2021 Mar; 25(1):67-73. PubMed ID: 32787515
[TBL] [Abstract][Full Text] [Related]
2. Beta-adrenergic receptor blockade as a therapeutic approach for suppressing the renin-angiotensin-aldosterone system in normotensive and hypertensive subjects.
Blumenfeld JD; Sealey JE; Mann SJ; Bragat A; Marion R; Pecker MS; Sotelo J; August P; Pickering TG; Laragh JH
Am J Hypertens; 1999 May; 12(5):451-9. PubMed ID: 10342782
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II in Decompensated Cirrhosis Complicated by Septic Shock.
Coleman PJ; Nissen AP; Kim DE; Ainsworth CR; McCurdy MT; Mazzeffi MA; Chow JH
Semin Cardiothorac Vasc Anesth; 2020 Sep; 24(3):266-272. PubMed ID: 31540560
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II in Refractory Septic Shock.
Antonucci E; Gleeson PJ; Annoni F; Agosta S; Orlando S; Taccone FS; Velissaris D; Scolletta S
Shock; 2017 May; 47(5):560-566. PubMed ID: 27879559
[TBL] [Abstract][Full Text] [Related]
5. Dysfunction of the renin-angiotensin-aldosterone system in human septic shock.
Schaich CL; Leisman DE; Goldberg MB; Filbin MR; Khanna AK; Chappell MC
Peptides; 2024 Jun; 176():171201. PubMed ID: 38555976
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Vasopressin for Septic Shock in Patients on Chronic Renin-Angiotensin-Aldosterone System Inhibitors.
Erwin BL; Denaburg MA; Barker AB; McArdle PJ; Windham ST; Morgan CJ
Crit Care Med; 2017 Dec; 45(12):e1226-e1232. PubMed ID: 28991825
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II in septic shock.
Jadhav AP; Sadaka FG
Am J Emerg Med; 2019 Jun; 37(6):1169-1174. PubMed ID: 30935784
[TBL] [Abstract][Full Text] [Related]
8. Classic and Nonclassic Renin-Angiotensin Systems in the Critically Ill.
Bitker L; Burrell LM
Crit Care Clin; 2019 Apr; 35(2):213-227. PubMed ID: 30784605
[TBL] [Abstract][Full Text] [Related]
9. The state and responsiveness of the renin-angiotensin-aldosterone system in patients with type II diabetes mellitus.
Price DA; De'Oliveira JM; Fisher ND; Williams GH; Hollenberg NK
Am J Hypertens; 1999 Apr; 12(4 Pt 1):348-55. PubMed ID: 10232494
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II reactivation and aldosterone escape phenomena in renin-angiotensin-aldosterone system blockade: is oral renin inhibition the solution?
Athyros VG; Mikhailidis DP; Kakafika AI; Tziomalos K; Karagiannis A
Expert Opin Pharmacother; 2007 Apr; 8(5):529-35. PubMed ID: 17376010
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II in septic shock.
Corrêa TD; Takala J; Jakob SM
Crit Care; 2015 Mar; 19(1):98. PubMed ID: 25886853
[TBL] [Abstract][Full Text] [Related]
12. Modulation of the renin-angiotensin-aldosterone system in sepsis: a new therapeutic approach?
Salgado DR; Rocco JR; Silva E; Vincent JL
Expert Opin Ther Targets; 2010 Jan; 14(1):11-20. PubMed ID: 20001206
[TBL] [Abstract][Full Text] [Related]
13. Identifying a disease-specific renin-angiotensin-aldosterone system fingerprint in patients with primary adrenal insufficiency.
Wolf P; Mayr J; Beiglböck H; Fellinger P; Winhofer Y; Poglitsch M; Gessl A; Kautzky-Willer A; Luger A; Krebs M
Eur J Endocrinol; 2019 Jul; 181(1):39-44. PubMed ID: 31075757
[TBL] [Abstract][Full Text] [Related]
14. The scientific rationale and study protocol for the DPP3, Angiotensin II, and Renin Kinetics in Sepsis (DARK-Sepsis) randomized controlled trial: serum biomarkers to predict response to angiotensin II versus standard-of-care vasopressor therapy in the treatment of septic shock.
Teixeira JP; Perez Ingles D; Barton JB; Dean JT; Garcia P; Kunkel SJ; Sarangarm P; Weiss NK; Schaich CL; Busse LW; Nielsen ND
Trials; 2024 Mar; 25(1):182. PubMed ID: 38475822
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II (Giapreza) for septic shock.
Med Lett Drugs Ther; 2018 Dec; 60(1561):199-200. PubMed ID: 30653477
[No Abstract] [Full Text] [Related]
16. Renin-Angiotensin-aldosterone system and hypothalamic-pituitary-adrenal axis in hospitalized newborn foals.
Dembek KA; Onasch K; Hurcombe SD; MacGillivray KC; Slovis NM; Barr BS; Reed SM; Toribio RE
J Vet Intern Med; 2013; 27(2):331-8. PubMed ID: 23398197
[TBL] [Abstract][Full Text] [Related]
17. Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease.
Jensen J; Henik RA; Brownfield M; Armstrong J
Am J Vet Res; 1997 May; 58(5):535-40. PubMed ID: 9140564
[TBL] [Abstract][Full Text] [Related]
18. Effects of losartan on the renin-angiotensin-aldosterone axis in essential hypertension.
Bauer IH; Reams GP; Wu Z; Lau-Sieckman A
J Hum Hypertens; 1995 Apr; 9(4):237-43. PubMed ID: 7595905
[TBL] [Abstract][Full Text] [Related]
19. Dysregulation of the renin-angiotensin system in septic shock: Mechanistic insights and application of angiotensin II in clinical management.
Senatore F; Balakumar P; Jagadeesh G
Pharmacol Res; 2021 Dec; 174():105916. PubMed ID: 34597810
[TBL] [Abstract][Full Text] [Related]
20. The predictability of renin-angiotensin-aldosterone system factors for clinical outcome in patients with acute decompensated heart failure.
Nakada Y; Takahama H; Kanzaki H; Sugano Y; Hasegawa T; Ohara T; Amaki M; Funada A; Yoshida A; Yasuda S; Ogawa H; Anzai T
Heart Vessels; 2016 Jun; 31(6):925-31. PubMed ID: 25964073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
